The RNA-binding protein (RBP) nucleolin promotes the expression of several proliferative proteins. Nucleolin levels are high in cancer cells, but the mechanisms that control nucleolin expression are unknown. Here, we show that nucleolin abundance is controlled posttranscriptionally via factors that associate with its 3 untranslated region (3UTR). The RBP HuR was found to interact with the nucleolin (NCL) 3UTR and specifically promoted nucleolin translation without affecting nucleolin mRNA levels. In human cervical carcinoma HeLa cells, analysis of a traceable NCL 3UTR bearing MS2 RNA hairpins revealed that NCL RNA was mobilized to processing bodies (PBs) after silencing HuR, suggesting that the repression of nucleolin translation may occur in PBs. Immunoprecipitation of MS2-tagged NCL 3UTR was used to screen for endogenous repressors of nucleolin synthesis. This search identified miR-494 as a microRNA that potently inhibited nucleolin expression, enhanced NCL mRNA association with argonaute-containing complexes, and induced NCL RNA transport to PBs. Importantly, miR-494 and HuR functionally competed for modulation of nucleolin expression. Moreover, the promotion of cell growth previously attributed to HuR was due in part to the HuR-elicited increase in nucleolin expression. Our collective findings indicate that nucleolin expression is positively regulated by HuR and negatively regulated via competition with miR-494.
Cell proliferation is strongly influenced through changes in the collection of expressed proteins. Their abundance is largely driven by posttranscriptional mechanisms, particularly changes in the stability and translation of mature mRNAs. These processes are controlled by two main types of mRNA-interacting factors: RNA-binding proteins (RBPs) and noncoding RNAs (46, 47) . Numerous RBPs that affect the stability and translation of mRNAs encoding proliferative proteins have been described, including elav/Hu proteins (the ubiquitous HuR and the primarily neuronal HuB, HuC, and HuD), AU-binding factor 1 (AUF1), tristetraprolin (TTP), KH domain-containing RBP (KSRP), the T-cell intracellular antigen 1 (TIA-1) and related (TIAR) proteins, nuclear factor 90 (NF90), polypyrimidine tract-binding protein (PTB), and CUG repeat binding protein 1 (CUGBP1) (16, 26, 28, 35, 43, 50, 53, 63, 65) . Together, these RBPs govern the expression of cyclins A2, B1, D1, and E, cyclin-dependent kinases (cdk's [e.g., cdk4]), cdk inhibitory proteins (e.g., p21 and p27), and other cell cycle regulatory proteins and transcription factors (e.g., c-myc, p53, c-fos, and c-jun) (reviewed in reference 4).
The RBP nucleolin has also been implicated in controlling cell proliferation (57) . Nucleolin interacts with RNA via four RNA-recognition motifs (RRMs) and a C-terminal, glycinearginine-rich domain (25, 30, 45, 60) . Nucleolin is prominently abundant in the nucleolus, where it interacts with precursor rRNA and assists in its maturation and processing (12, 24, 25, 55) ; accordingly, nucleolin downregulation disrupted nucleolar function, impairing cell cycle progression and centrosome duplication (57) . In the cytoplasm, nucleolin interacts with mature mammalian mRNAs, typically at the 3Ј untranslated region (3ЈUTR), but sometimes at the 5ЈUTR and coding region (CR) (7) . The actions of nucleolin on target mRNAs vary widely depending on the experimental system and the bound mRNA. Besides a role in nucleocytoplasmic transport, nucleolin was shown to promote the stability of mRNAs encoding ␤-globin, amyloid precursor protein (APP), gastrin, B-cell leukemia/lymphoma 2 (Bcl-2), Bcl-x L , interleukin 2 (IL-2), and growth arrest and DNA damage-inducible 45 (Gadd45␣) (18, 29, 39, 49, 52, 66) . It also reduced the translation of p53 and prostaglandin endoperoxide H synthase 1 (PGHS1) (14, 59) . Recently, nucleolin was shown to associate with dozens of mRNAs encoding proteins with roles in cell growth and proliferation as well as in cancer, including Bcl-2, p53, cyclin I, and Akt1 (7) . Additionally, nucleolin was found to promote the translation of matrix metalloprotease 9 (MMP9), several selenoproteins, and a subset of mRNAs bearing a G-rich element (7, 22, 44) . Nucleolin was also found on the cell surface in many cancer cells and thus serves as a cancer marker (19, 31, 54) . As a DNA-binding protein, nucleolin induces chromatin decondensation by the remodeling complex SWI/SNF (switch/ sucrose nonfermentable in yeast), functions as a histone chaperone, facilitates transcription by RNA polymerases I and II, and modulates DNA replication (8, 45, 61) .
While nucleolin is expressed ubiquitously, its levels are significantly elevated in many cancer cells. Given its influence on the expression of cancer proteins (e.g., Bcl-2, Bcl-x L , p53, and MMP9), nucleolin has become an important target of anticancer therapy in recent years. In addition, nucleolin's involvement in other pathologies, such as viral infections, autoimmune diseases, graft-versus-host reaction, and Alzheimer's and Parkinson's diseases (9, 15, 17, 20, 58, 61), has increased its diagnostic and therapeutic value. However, very little is known about the regulation of nucleolin expression.
Here, we sought to investigate the molecular mechanisms that govern nucleolin expression. We previously identified nucleolin as a putative target of the RBP HuR (5, 6, 41) . In this study, we obtained evidence that HuR associated with the 3ЈUTR of the nucleolin (NCL) mRNA and that this interaction promoted nucleolin translation without affecting NCL mRNA half-life. Further insight into the enhancement of nucleolin expression by HuR came through the identification of a microRNA, miR-494, which lowered nucleolin expression by competing with HuR. MicroRNAs (ϳ22-nucleotide [nt]-long noncoding RNAs) are integral components of argonaute (Ago)-containing RNA-induced silencing complexes (RISC) and typically function as repressors of gene expression. As part of RISC/Ago, microRNAs interact with mRNAs with partial complementarity and generally reduce mRNA stability and/or translation (34); these processes can occur in specialized cytoplasmic regions, including processing bodies (PBs) (10, 40) . Our results indicate that HuR competed with miR-494 for modulation of nucleolin production, with HuR preventing the recruitment of NCL mRNA to PBs and miR-494 favoring it. The competing actions of HuR and miR-494 influenced nucleolin expression, in turn modulating cell proliferation and survival.
MATERIALS AND METHODS
Cell culture, transfection, small RNAs, and plasmids. HeLa cells were cultured in Dulbecco's modified essential medium (DMEM; Invitrogen) supplemented with 10% fetal bovine serum and antibiotics. miRNAs (Ambion), control small interfering RNA (Ctrl siRNA; Qiagen), HuR siRNA (Qiagen), and enhanced green fluorescent protein (EGFP) reporter plasmids were transfected with Lipofectamine-RNAiMAX or Lipofectamine 2000 (Invitrogen). Plasmid DNAs were transfected at 25 ng/ml [pEGFP, pEGFP-NCL(3Ј), and pEGFP-NCL(3Јmut)], 0.5 g/ml [pEGFP, pEGFP-NCL(CR), and pMS2-YFP (expressing yellow fluorescent protein)], or 1 g/ml [pMS2-RL and pMS2-RL-NCL(3Ј)]. The Renilla luciferase coding region (RL), was added in order to provide a reporter open reading frame to the MS2 RNA-containing constructs. NCL 3ЈUTR reporter constructs were made by inserting cDNA corresponding to the NCL 3ЈUTR into pEGFP-C1 or pMS2. pMS2, or pMS2-YFP plasmids were described previously (38) . EGFP reporters were cloned by inserting specific fragments from the NCL 3ЈUTR into pEGFP-C1 (BD Bioscience). The seed region of the miR-494 binding site on the NCL 3ЈUTR in pEGFP-NCL(3Јmut) was disrupted by site-directed mutagenesis (Stratagene).
Western blot analysis. Whole-cell lysates were prepared using radioimmunoprecipitation assay (RIPA) buffer (10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% NP-40, 1 mM EDTA, 0.1% SDS, 1 mM dithiothreitol), separated by electrophoresis in SDS-containing polyacrylamide gels, and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore). Incubations with primary antibodies to detect nucleolin, HuR, or EGFP (Santa Cruz Biotech) or to detect ␤-actin (Abcam) were followed by incubations with the appropriate secondary antibodies conjugated with horseradish peroxidase (HRP) (GE Healthcare) and by detection using enhanced luminescence (GE Healthcare).
RNA analysis. Total RNA was prepared from whole cells, gradient fractions, or RNP immunoprecipitation (IP) samples using TRIzol (Invitrogen). After reverse transcription (RT) using random hexamers and SSII reverse transcriptase (Invitrogen) for mRNA or using a QuantiMir RT kit (System Biosciences) for mature miRNA and U6 snRNA, the abundance of transcripts was assessed by quantitative PCR (qPCR) analysis using the SYBR green PCR master mix (Kapa Biosystems) and gene-specific primer sets (below). RT-qPCR analysis was performed on Applied Biosystems model 7300 and 7900 instruments. The forward and reverse primers used were TGCACCACCAACTGCTTAGC and GGCATGGAC TGTGGTCATGAG for GAPDH (glyceraldehyde-3-phosphate dehydrogenase), GAAGGAAATGGCCAAACAGA and ACGCTTTCTCCAGGTCTTCA for nucleolin, CGCAGAGATTCAGGTTCTCC and CCAAACCCTTTGCACT TGTT for HuR, and TAAACGGCCACAAGTTCAGCGT and AAGTCGTGCT GCTTCATGTGGT for EGFP. To measure the abundance of mature microRNAs, the forward primers were TGAAACATACACGGGAAACCTC for miR-494 and CACCACGTTTATACGCCGGTG for U6 snRNA (QuantiMir detection assay; System Biosciences). miR-494 miRNA was from Applied Biosystems.
RNP IP analysis was performed using as primary antibodies anti-HuR, anti-GFP, or control IgG (Santa Cruz Biotech.) or anti-pan Ago antibody (Millipore), as explained in reference 33. RNA in the IP samples was extracted and further analyzed by RT-qPCR using the primers listed above.
Biotin pulldown analysis. The primers used to prepare biotinylated transcripts spanning the NCL mRNA (NM_005381.2) are listed below. After purification of the template PCR products, biotinylated transcripts were synthesized using the MaxiScript T7 kit (Ambion), whole-cell lysates (200 g per sample) were incubated with 3 g of purified biotinylated transcripts for 30 min at room temperature, and then complexes were isolated with streptavidin-coupled Dynabeads (Invitrogen). Proteins present in the pulldown material were studied by Western blot analysis as described previously (7) . To synthesize biotinylated transcripts, PCR fragments were prepared using forward primers that contained the T7 RNA polymerase promoter sequence: CCAAGCTTCTAATACGACTCACTA TAGGGAGA [presented as "(T7)" below]. Primers to amplify PCR templates for the synthesis of NCL 5ЈUTR (forward and reverse, respectively) were (T7) CTTTCGCCTCAGTCTCGAGCTCT and TGATGGCGGCGGAGTGTGAA GCGG, and primers to synthesize the NCL coding region (CR) were (T7)ATG GTGAAGCTCGCGAAG and CTATTCAAACTTCGTCTTCTTTC. PCR templates to synthesize the NCL 3ЈUTR fragments were prepared using primers (T7)CTTCTGTCCCTCTGCTTT and AACCAACACGGTATTGCC for fragment a, (T7)TCCGTCTAGTTAACATTTCAAG and CAAAACCCAAACTA TTTGTAGG for fragment b, and (T7)TGTACAAAACCATTTTTTCCTAC and CTGGCACCAGAGTTGACT for fragment c. The biotinylated GAPDH gene (GAPDH) 3ЈUTR was synthesized using the primer pair (T7)CCTCAAC GACCACTTTGTCA and GGTTGAGCACAGGGTACTTTATT.
Biotin pulldown analysis to narrow down the HuR binding site in the NCL 3ЈUTR was performed by synthesizing small RNA fragments using as templates the short DNA segments obtained after annealing the following oligomer pairs: Translation assays. Polyribosome fractionation assays were carried out as explained in reference 23. In short, cells were incubated with cycloheximide (Sigma) (100 g/ml, 15 min), and cytoplasmic lysates (500 l) were fractionated by centrifugation through 15 to 60% linear sucrose gradients and divided into 20 fractions for RT-qPCR analysis to determine the distribution of NCL mRNA and GAPDH mRNAs.
For nascent translation assays, HeLa cells were incubated with 1 mCi
S]methionine and L-[
35 S]cysteine (NEN/Perkin Elmer) per 60-mm plate for 15 min. After lysis, IP reactions were carried out (16 h, 4°C) using IgG (Santa Cruz) or anti-GAPDH or antinucleolin antibodies, and the reaction products were resolved by SDS-PAGE, transferred to PVDF filters, and visualized using a PhosphorImager (Molecular Dynamics).
Interaction between mRNA and microRNA. The interaction of the indicated microRNAs was tested by RNP IP analysis using anti-GFP antibody. HeLa cells were cotransfected with plasmid pMS2-RL or pMS2-RL-NCL(3Ј) and pMS2-YFP. Sixteen hours later, candidate microRNAs enriched in GFP IP samples were assessed by RT-qPCR analysis and by the enrichment in microRNAs in pMS2-RL-NCL(3Ј)-transfected cells relative to that in pMS2-RL-transfected cells.
Immunocytochemistry. HeLa cells were fixed with 2% formaldehyde, permeabilized with 0.2% Triton X-100, and blocked with 5% bovine serum albumin (BSA). After incubation with a primary antibody recognizing Dcp1a (Abcam), an Alexa Fluor 568-conjugated secondary antibody (Invitrogen) was used to detect primary antibody-antigen complexes (red). YFP fluorescence was green. Images 4220 TOMINAGA ET AL. MOL. CELL. BIOL.
were acquired using Axio Observer microscope (Zeiss) with AxioVision 4.7 Zeiss image processing software or with LSM 510 Meta (Zeiss). Confocal microscopy images were acquired with the Z-sectioning mode with 15 slices and 0.4-m spacing and merged using maximum intensity.
RESULTS

RNA-binding protein HuR interacts with NCL mRNA.
Earlier en masse searches identified NCL mRNA as a putative target of HuR (5, 6, 41) . To investigate if HuR regulated nucleolin expression, we began by examining the interaction of HuR with the NCL mRNA in human cervical carcinoma (HeLa) cells. First, we performed ribonucleoprotein (RNP) immunoprecipitation (IP) assays using anti-HuR antibodies under conditions that preserved RNP integrity. After isolating RNA from the IP material and subjecting it to reverse transcription (RT) and quantitative real-time PCR (qPCR) analysis, we monitored the association of NCL mRNA with HuR. As shown in Fig. 1A , NCL mRNA was enriched more than 10-fold in HuR IP samples compared with IgG IP samples, supporting the existence of NCL mRNA-HuR complexes. Second, we studied if endogenous HuR bound to ectopic NCL mRNAs by using the biotin pulldown assay. Biotinylated RNAs VOL. 31, 2011 HuR COMPETES WITH miR-494 TO REGULATE NUCLEOLIN LEVELS 4221 spanning the NCL 5ЈUTR, CR, and 3ЈUTR were synthesized (Fig. 1B, top) , and their interaction with HuR was studied. We did not detect any association of HuR with biotinylated RNAs containing the NCL 5ЈUTR, CR, or proximal 3ЈUTR. However, HuR associated prominently with 3ЈUTR fragments b and c. No binding was observed between HuR and a negative control transcript spanning the 3ЈUTR of GAPDH mRNA. Further subdivision of the 3ЈUTR revealed that HuR interacted more strongly with segment c-1, spanning positions 2573 to 2600 (Fig. 1C) . HuR regulates nucleolin expression. To test the functional consequences of the association between HuR and NCL mRNA, we studied if modulation of HuR abundance in HeLa cells affected nucleolin expression. As shown, silencing HuR by using specific HuR-directed small interfering RNA (siRNA) markedly decreased nucleolin protein levels but did not significantly lower NCL mRNA abundance ( Fig. 2A and B) , nor did it affect NCL mRNA stability (not shown). Conversely, overexpression of HuR (as the fusion protein HuR-TAP) significantly increased nucleolin levels but did not affect the NCL mRNA concentration (Fig. 2C and D) .
HuR promoted the translation of several target mRNAs without affecting their stability, as reported for mRNAs encoding prothymosin ␣, p53, cytochrome c, and hypoxia-inducible factor 1␣ (HIF-1␣) (23, 32, 36, 42) . To test if HuR similarly enhanced the translation of NCL mRNA, we tested the sizes of polysomes associated with NCL mRNA in HeLa cells expressing either normal HuR levels (Ctrl siRNA) or reduced HuR levels (HuR siRNA). Following the fractionation of cytoplasmic lysates through sucrose gradients (15 to 60%), the lightest components sedimented at the top (fractions 1 to 5), small (40S) and large (60S) ribosomal subunits and monosomes (80S) appeared in fractions 6 to 10, and progressively larger polysomes, ranging from low to high molecular weight (LMWP and HMWP, respectively) appeared in fractions 12 to 20 (Fig.  3A) . Forty-eight hours after siRNA transfection, the distribution of NCL mRNA peaked at fractions 14 and 18 in control (Ctrl siRNA) cells, but these peaks shifted down and leftward in HuR siRNA cells, indicating that when HuR levels were lower, the sizes of NCL mRNA polysomes were also reduced, consistent with a decline in nucleolin translation (Fig. 3B, top) . The distributions of the GAPDH mRNA, encoding a house- keeping protein, largely overlapped between the two groups (Fig. 3B, bottom) . According to these results, HuR appears to contribute to enhancing nucleolin translation by increasing the initiation of NCL mRNA translation. Additional evidence that HuR promoted nucleolin translation came from studies to assess de novo nucleolin biosynthesis. (Fig. 3C) . Taking into consideration that HuR silencing did not affect NCL mRNA levels (Fig. 2B) or nucleo- ]cysteine for 15 min, whereupon cell lysates were prepared, and the levels of newly synthesized nucleolin and GAPDH were assessed by immunoprecipitation with antinucleolin and anti-GAPDH antibodies, respectively, followed by separation by SDS-PAGE and visualization using a PhosphorImager. Data in panels A to C are representative of three independent experiments.
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HuR COMPETES WITH miR-494 TO REGULATE NUCLEOLIN LEVELS 4223 lin protein stability (not shown), these data indicate that HuR promotes nucleolin translation. Further experiments revealed that HuR influenced nucleolin translation through the NCL 3ЈUTR. A heterologous reporter construct expressing a chimeric RNA that spanned the EGFP gene (EGFP) CR and the NCL 3ЈUTR was constructed and studied (Fig. 4A) . As shown, HuR silencing decreased significantly the expression of EGFP (Fig. 4B ) from the reporter chimeric plasmid pEGFP-NCL(3Ј) but not from the parent control plasmid, pEGFP. This reduction was due to changes in translation and not due to changes in the levels or stability of the chimeric RNA, since the levels of the ectopic reporter RNAs [EGFP mRNA and EGFP-NCL(3Ј) mRNA] did not significantly change after silencing HuR (Fig. 4C) . Taken together, these data indicate that HuR promotes nucleolin translation via the NCL 3ЈUTR.
HuR excludes NCL mRNA from RISC/Ago complexes and from PBs. We sought to further examine the mechanisms whereby HuR promotes nucleolin translation. We hypothesized that the absence of HuR may facilitate the binding of a translational repressor of NCL mRNA, resulting in reduced translation of nucleolin. A plausible candidate repressor was the microRNA/RISC/Ago (RNA-induced silencing complex/ Argonaute) machinery. To measure if NCL mRNA associated with RISC/Ago, we performed RNP IP analysis using an antibody that recognized all isoforms of the protein Ago, a critical component of the RISC. As shown, silencing of HuR increased the interaction of Ago with NCL mRNA (Fig. 5A) . These results suggested that HuR might prevent microRNA/RISCmediated translational repression.
To identify which microRNA(s) interacted with NCL mRNA, we employed a recently reported method based on the tagging of the RNA of interest (NCL mRNA in this case) with bacteriophage MS2 RNA hairpins (56) . Plasmids pMS2-RL (containing the Renilla luciferase gene [RL] CR) and pMS2-RL-NCL(3Ј) were constructed to express reporter (MS2-tagged) MS2-RL and MS2-RL-NCL(3Ј) mRNAs. Each culture was also transfected with plasmid pMS2-YFP, which expresses a fusion protein that has a strong nuclear localization signal (NLS), is fluorescent (via the YFP domain), and recognizes the MS2 RNA hairpins (via the MS2-binding protein region) (Fig.  5B) . The plasmids expressing reporter RNAs were transfected along with pMS2-YFP; 24 h later, the localization of the reporter RNAs was studied in cells that expressed different levels of HuR. As shown in Fig. 5C , the YFP fluorescent signal (green) was almost exclusively nuclear in all of the cells, due to the NLS present in the fusion MS2-YFP protein; however, in HuR siRNA cells, there was a sizeable amount of fluorescence in the cytoplasm, and some of the cytoplasmic fluorescent signal overlapped with the signals of Dcp1a, a PB marker (overlapping signals are displayed yellow in the "merge" images). These findings revealed that silencing HuR permitted the colocalization of ectopic NCL RNA in PBs, while the NCL RNA was excluded from PBs in cells that expressed normal HuR levels (Ctrl siRNA). Given that microRNA/RISC can elicit translational repression at PBs (40), we postulated that a microRNA might be implicated in recruiting NCL mRNA into PBs when the cellular HuR levels are low.
miR-494 represses nucleolin expression by competing with HuR, recruiting NCL mRNA to PBs. This MS2 RNA-tagging system was further used in order to identify the microRNAs that interact with the NCL 3ЈUTR. First, cells were transfected with pMS2-YFP and with either pMS2-RL or pMS2-RL-NCL(3Ј), as explained in Fig. 5C . The MS2-YFP fusion protein HuR COMPETES WITH miR-494 TO REGULATE NUCLEOLIN LEVELS(bound to the MS2-tagged RNA) was then subjected to IP using anti-GFP antibody, which selectively detected RNP complexes containing MS2-YFP, MS2-tagged RNA, and any microRNAs bound to the tagged mRNA (shown schematically in Fig. 6A ). As previously reported (56) , this IP selectively enriched in microRNAs associated with an RNA of interest. Second, we predicted computationally all of the possible microRNAs that could interact with the NCL 3ЈUTR, using the programs TargetScan, microRNA org, and miRDB. (Fig. 6C) . Importantly, HuR binding to NCL mRNA was potently reduced when miR-494 was overexpressed, suggesting that miR- 494 was capable of competing with HuR, displacing it from the NCL mRNA (Fig. 6D) . We tested if miR-494 directly affected nucleolin expression by studying the expression of a reporter construct carrying the intact NCL 3ЈUTR [pEGFP-NCL(3Ј)] relative to the expression of a reporter construct in which the region of complementarity with miR-494 in the NCL 3ЈUTR was mutated [pEGFP-NCL(3Јmut)] (Fig. 7A) . As shown, EGFP expressed from the parent vector (pEGFP) in transfected HeLa cells did not change after overexpressing miR-494; in contrast, expression of EGFP from cells transfected with pEGFP-NCL(3Ј) declined markedly (Fig. 7B) . Importantly, however, destroying the site of interaction with miR-494 rendered the reporter refractory to miR-494-mediated reduction of EGFP levels (Fig. 7B) . Overexpression of miR-494 lowered EGFP-NCL(3Ј) mRNA levels significantly (Fig. 7C) , suggesting that miR-494, besides displacing HuR, may also affect NCL mRNA stability.
Overexpression of miR-494 in HeLa cells modestly lowered NCL mRNA levels (by close to 25% [Fig. 8A] ) and significantly enriched the association of NCL mRNA with Ago-containing complexes (Fig. 8B) . In agreement with the notion that miR-494 competed with HuR functionally, miR-494 overexpression in cells transfected with the reporters described in Fig.  5 triggered an increase in localization of the chimeric MS2-RL-NCL(3Ј) mRNA into PBs, while it did not affect the subcytoplasmic distribution of control MS2-RL mRNA (Fig. 8C) .
HuR enhances cell proliferation in part by promoting nucleolin expression. As reported previously (5), silencing HuR significantly reduced the proliferation of HeLa cells (Fig.  9A) . Interestingly, overexpression of nucleolin in HuR siRNA cells using a vector that transcribed only the NCL CR significantly restored cell numbers, indicating that HuR promoted cell proliferation in part by elevating nucleolin levels. Overexpression of miR-494 similarly lowered the number of cells in the population, and this effect was likewise reversed if nucleolin levels were ectopically increased using a vector [pEGFP-NCL(CR)] that lacked the regulatory NCL 3ЈUTR (Fig. 9A) . The changes in cell number elicited by HuR, nucleolin, and miR-494 were at least partly due to alterations in apoptosis, since the levels of cleaved PARP (a marker of apoptosis) increased after HuR silencing and after miR-494 overexpression, but in both instances, overexpression of nucleolin partially rescued apoptosis (Fig. 9B) . Taken together, these findings indicate that HuR promotes cell proliferation and prevents apoptosis at least in part by promoting nucleolin expression and that these effects are antagonized by miR-494.
DISCUSSION
Nucleolin is known to participate in important cellular processes, such as chromatin dynamics, ribosome biogenesis, DNA replication, cell proliferation, and cell survival. Its role is also recognized in pathologies like cancer, autoimmunity, and neurodegeneration. Although nucleolin has these critical functions, the mechanisms that control nucleolin expression have not been reported. Here we have identified two potent posttranscriptional regulators of nucleolin expression: the RBP HuR and the microRNA miR-494. Both of these molecules interact with the NCL 3ЈUTR [NCL(3Ј)] and influence nucleolin biosynthesis: HuR enhances it, and miR-494 represses it. HuR and miR-494 bind the NCL 3ЈUTR competitively, and each has an opposite effect on the localization of NCL mRNA in PBs, cytoplasmic foci where mRNAs are subject to translational repression and mRNA decay. Our data indicate that HuR excludes the NCL mRNA from PBs, while miR-494 recruits NCL mRNA to PBs. Although controversy remains regarding the role of PBs in gene regulation, our findings are consistent with HuR precluding the localization of NCL mRNA within a cellular domain where mRNAs can be degraded and translationally repressed, while miR-494 has the opposite influence.
The discovery that the levels of the RBP nucleolin are controlled by another RBP (HuR) and by a microRNA (miR-494) adds to a growing body of evidence that expression of posttranscriptional regulatory factors is controlled by other posttranscriptional regulatory factors. For example, RBPs HuR, AUF1, TIA-1, TIAR, KSRP, NF90, and TTP were shown to associate with their cognate mRNAs, and in several instances, they auto-and cross-regulated their expression (13, 51, 64) . Similarly, several microRNAs have been found to modulate the expression of several RBPs; for example, miR-519 and miR-125 lowered HuR levels and miR-375 reduced HuD production (2, 5, 27 ). It appears that in instances in which the cellular fate depends critically on posttranscriptional gene regulation (for example, after severe DNA damage that shuts down de novo transcription), posttranscriptional regulators rely on each other and on preexisting mRNAs in order to properly adapt the patterns of expressed proteins.
Examples of posttranscriptional regulation of a target of HuR via the joint influence of HuR and a specific microRNA are also on the rise. For example, HuR antagonizes miR-122 to regulate expression of CAT-1 mRNA (11), antagonizes miR548c-3p to regulate the expression of TOP2A (56) , and cooperates with let-7 in repressing c-Myc expression (33) . MicroRNA sites are often present near HuR sites (37, 48) , suggesting that in some cases HuR and microRNA could compete via their physical interaction with mRNAs (possibly via steric hindrance). However, in the above examples (11, 33, 56) , HuR and the coregulatory microRNAs bind at distances up to several hundreds of bases apart; likewise in this report, the miR-494 site and the main interaction site for HuR (c-1) are 44 bases apart on the NCL 3ЈUTR. RNA structure and folding analyses will be needed to investigate systematically how bind- VOL. 31, 2011 HuR COMPETES WITH miR-494 TO REGULATE NUCLEOLIN LEVELS 4229 ing of HuR in one area of the 3ЈUTR affects association of a microRNA/RISC in a remote site and vice versa. It was interesting to find that the HuR-elicited promotion of cell proliferation and inhibition of apoptosis was significantly dependent on its upregulation of nucleolin. Nucleolin inhibits apoptosis by enhancing the expression of antiapoptotic proteins such as Bcl-2 and Bcl-x L and increases cell division by elevating expression of many cancer-, cell growth-, and proliferation-associated proteins (e.g., cyclin I) (7) and by promoting processes like DNA replication and transcription (58) . HuR helps to implement a malignant phenotype by controlling the production of subsets of cancer-related proteins, including proteins that promote cell division (e.g., cyclins), degrade the extracellular matrix (e.g., matrix metalloproteases), induce angiogenesis (e.g., HIF-1␣, vascular endothelial growth factor [VEGF], and cyclooxygenase 2), inhibit apoptosis (e.g., Bcl-2, prothymosin ␣, and sirtuin 1), and evade immune recognition (e.g., transforming growth factor ␤) (1). In light of the findings reported here, HuR is an upstream regulator of nucleolin expression and hence nucleolin's functions as inhibitor of apoptosis and promoter of cell proliferation. Thus, HuR and nucleolin appear to work in tandem to mediate these two cellular functions and thereby favor a pro-oncogenic phenotype. Whether HuR is also involved in other physiologic and pathological facets of nucleolin, such as neurodegeneration and autoimmunity, remains to be studied.
It will also be important to determine if miR-494, a strong inhibitor of nucleolin production, possesses antitumor activities. Overexpression of miR-494 triggered an increase in PARP cleavage (Fig. 9) , suggesting that miR-494 is proapoptotic; this effect was rescued by overexpression of nucleolin, indicating that miR-494 enhanced apoptosis specifically by lowering nucleolin levels. Other studies have also shown that miR-494 triggered growth arrest in bronchial epithelial cells (21) . Thus, it will be interesting to investigate if miR-494 can function more broadly as a tumor supressor microRNA. For example, miR-519 (a repressor of HuR translation) is much less abundant in cancer tissues than in noncancer tissues, and its overexpression in human carcinoma cells reduces tumorigenesis (3). It will be important to study systematically if miR-494 levels differ between tumor and normal tissues and whether miR-494 recapitulates the antitumorigenic effects of miR-519.
In conclusion, since nucleolin has been linked to numerous pathologies, understanding the mechanisms that control nucleolin is critical to designing specific approaches to modulate nucleolin levels. Here, we have identified two posttranscriptional regulators of nucleolin expression. Interventions directed toward HuR, miR-494, or other regulators of nucleolin expression can become promising therapies to combat diseases in which nucleolin is implicated, including cancer.
